Cipla ready to launch coronavirus COVID-19 treatment drug Favipiravir: CSIR
Mumbai-based pharmaceutical firm Cipla is ready to launch coronavirus drug Favipiravir for the treatment of COVID-19 patients, according to an official statement released by the Council of Scientific and Industrial Research (CSIR) on Thursday (July 23, 2020).
Jul 24, 2020, 10:38 AM IST